Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05777343
Other study ID # RCTCognitiveTraining
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 10, 2023
Est. completion date March 1, 2024

Study information

Verified date November 2023
Source Aveiro University
Contact Ellen P. Nery, Ms.
Phone +351234370200
Email ellen.nery@ua.pt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).


Description:

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP). It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training). Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 83
Est. completion date March 1, 2024
Est. primary completion date February 10, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - have chronic idiopathic LBP - report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale - 18 to 64 years old - Be able to read, write and speak Portuguese - Asses to personal computer and internet for those receiving cognitive training Exclusion Criteria: - individuals receiving any chronic treatment for their pain - symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance); - a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela; - having a diagnosis of ongoing psychiatric disease - having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Experimental
Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
Exercise and PNE
Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
Cognitive training
Online sessions of cognitive training.

Locations

Country Name City State
Portugal University of Aveiro Aveiro

Sponsors (3)

Lead Sponsor Collaborator
Aveiro University Fundação para a Ciência e a Tecnologia, RISE Study Group

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numeric Pain Rating Scale Numeric Pain Rating Scale Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". baseline
Primary Numeric Pain Rating Scale Numeric Pain Rating Scale Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". post-intervention - 8 weeks
Primary Numeric Pain Rating Scale Numeric Pain Rating Scale Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". 3 months follow-up
Secondary Cognitive Function Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. baseline
Secondary Cognitive Function Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. post-intervention - 8 weeks
Secondary Cognitive Function Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. 3 months follow-up.
Secondary Roland Morris disability questionnaire The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. baseline
Secondary Roland Morris disability questionnaire The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. post-intervention - 8 weeks
Secondary Roland Morris disability questionnaire The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. 3 months follow-up
Secondary Central sensitization Inventory The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. baseline
Secondary Central sensitization Inventory The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. post-intervention - 8 weeks
Secondary Central sensitization Inventory The central sensitization inventory (CSI)assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. 3 months follow-up
Secondary Hospital Anxiety and Depression Scale (HADS) HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. baseline
Secondary Hospital Anxiety and Depression Scale (HADS) HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. post-intervention - 8 weeks
Secondary Hospital Anxiety and Depression Scale (HADS) HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. 3 months follow-up.
Secondary TAMPA Scale of Kinesiophobia The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. baseline
Secondary TAMPA Scale of Kinesiophobia The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. post-intervention - 8 weeks
Secondary TAMPA Scale of Kinesiophobia The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. 3 months follow-up.
Secondary Pain Catastrophizing Scale The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. Baseline
Secondary Pain Catastrophizing Scale The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. post-intervention - 8 weeks
Secondary Pain Catastrophizing Scale The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. 3 months follow-up.
Secondary Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs) The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. baseline
Secondary Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs) The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. post-intervention - 8 weeks
Secondary Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs) The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. 3 months follow-up.
Secondary Two-point discrimination Two-point discrimination is used to assess cortical reorganization. baseline
Secondary Two-point discrimination Two-point discrimination is used to assess cortical reorganization. post-intervention - 8 weeks
Secondary Two-point discrimination Two-point discrimination is used to assess cortical reorganization. 3 months follow-up
Secondary Patient's Global Impression of Change (PGIC) PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. post-intervention - 8 weeks
Secondary Patient's Global Impression of Change (PGIC) PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. 3 months follow-up.
See also
  Status Clinical Trial Phase
Recruiting NCT05963451 - Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
Completed NCT04283370 - A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain N/A
Completed NCT04824547 - Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals N/A
Completed NCT04046419 - In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
Completed NCT04399772 - COgNitive FuncTional Therapy+ for Chronic Low Back paIn N/A
Recruiting NCT05780021 - Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation N/A
Completed NCT04555278 - Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain N/A
Completed NCT04530071 - Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain Phase 1/Phase 2
Not yet recruiting NCT06347328 - The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain N/A
Not yet recruiting NCT06080464 - Clinician Satisfaction With the VERABAND™ N/A
Not yet recruiting NCT04940715 - Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain N/A
Recruiting NCT04683718 - A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management N/A
Recruiting NCT05724160 - Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain N/A
Recruiting NCT06030128 - Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults N/A
Recruiting NCT05846087 - Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia N/A
Active, not recruiting NCT05396014 - The BEST Trial: Biomarkers for Evaluating Spine Treatments Phase 4
Active, not recruiting NCT06140862 - Ankle Spine Syndrome "RAFFET Syndrome II N/A
Completed NCT05512338 - Motivation and Adherence to Exercise Recommendations N/A
Recruiting NCT05021146 - Essential Oil for Chronic Low Back Pain N/A
Completed NCT05120921 - Osteopathic Single CAse Research for Patients With Chronic Low Back Pain N/A